These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17151211)

  • 1. Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.
    Chawla A; Murphy G; Donnelly C; Booth CL; Johnson M; Parry JV; Phillips A; Geretti AM
    J Clin Microbiol; 2007 Feb; 45(2):415-20. PubMed ID: 17151211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection.
    Booth CL; Garcia-Diaz AM; Youle MS; Johnson MA; Phillips A; Geretti AM
    J Antimicrob Chemother; 2007 Mar; 59(3):517-24. PubMed ID: 17213262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low avidity antibody: a reliable method to diagnose a recent HIV-1 infection.
    Re MC; Schiavone P; Vitone F; Bon I; De Crignis E; Biagetti C; Alessandrini F; Gibellini D
    New Microbiol; 2008 Jan; 31(1):19-26. PubMed ID: 18437838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity.
    Suligoi B; Buttò S; Galli C; Bernasconi D; Salata RA; Tavoschi L; Chiappi M; Mugyenyi P; Pimpinelli F; Kityo C; Regine V; Rezza G
    J Clin Virol; 2008 Apr; 41(4):288-92. PubMed ID: 18248848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.
    Kiwanuka N; Laeyendecker O; Robb M; Kigozi G; Arroyo M; McCutchan F; Eller LA; Eller M; Makumbi F; Birx D; Wabwire-Mangen F; Serwadda D; Sewankambo NK; Quinn TC; Wawer M; Gray R
    J Infect Dis; 2008 Mar; 197(5):707-13. PubMed ID: 18266607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of high-avidity rubella-specific IgG antibody and titres in recent HIV seroconvertors and in patients progressing to the AIDS-related complex and AIDS.
    Thomas HI; Aird HC
    J Med Virol; 1999 Jul; 58(3):273-9. PubMed ID: 10447423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV-1 antibody avidity is correlated with clinical status in infected children.
    Sciascia C; Palomba E; Gay V; Tovo PA
    Pediatr AIDS HIV Infect; 1996 Feb; 7(1):14-9. PubMed ID: 11361468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human immunodeficiency virus type-1 from HIV-1 seropositive cases with undetectable viremia.
    Yang C; Li M; Cowart F; Rudolph D; Parekh B; McDougal JS; Lal RB
    J Clin Virol; 2004 Jul; 30(3):224-8. PubMed ID: 15135739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.
    Vasan A; Renjifo B; Hertzmark E; Chaplin B; Msamanga G; Essex M; Fawzi W; Hunter D
    Clin Infect Dis; 2006 Mar; 42(6):843-52. PubMed ID: 16477563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy.
    Re MC; Schiavone P; Bon I; Vitone F; De Crignis E; Biagetti C; Gibellini D
    Int J Infect Dis; 2010 Nov; 14(11):e1008-12. PubMed ID: 20869896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.
    Walker PR; Cilliers T; Choge IA; Taylor N; Cohen SS; Morris L
    J Med Virol; 2006 Oct; 78(10):1262-8. PubMed ID: 16927278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human Immunodeficiency Virus type 1 seroincidence estimate among a group of drug users: a new approach].
    Fernandes SB; Martins HC; Trigo H; Leitão E; Coutinho R; Paixão MT
    Acta Med Port; 2005; 18(1):37-44. PubMed ID: 16202333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.
    Kaleebu P; French N; Mahe C; Yirrell D; Watera C; Lyagoba F; Nakiyingi J; Rutebemberwa A; Morgan D; Weber J; Gilks C; Whitworth J
    J Infect Dis; 2002 May; 185(9):1244-50. PubMed ID: 12001041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women infected with HIV type 1 Brazilian variant, subtype B (B'-GWGR motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR motif).
    de Brito A; Komninakis SC; Novoa P; de Oliveira RM; Fonseca LA; Duarte AJ; Casseb J
    Clin Infect Dis; 2006 Dec; 43(11):1476-81. PubMed ID: 17083025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibody avidity: use for the diagnosis of HIV early infection].
    Le Guillou H; Le Meur A; Bourdon S; Riou M; Loison J; Fialaire P; Chennebault JM; Kouyoumdjian S; Payan C
    Ann Biol Clin (Paris); 2001; 59(1):41-7. PubMed ID: 11174099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an antibody avidity index method for detecting recent human immunodeficiency virus type 1 infection using an automated chemiluminescence immunoassay.
    Fernández G; Manzardo C; Montoliu A; Campbell C; Fernández G; Casabona J; Miró JM; Matas L; Rivaya B; González V
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):238-42. PubMed ID: 25060663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.
    Baeten JM; Chohan B; Lavreys L; Chohan V; McClelland RS; Certain L; Mandaliya K; Jaoko W; Overbaugh J
    J Infect Dis; 2007 Apr; 195(8):1177-80. PubMed ID: 17357054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
    Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
    Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States.
    Sullivan PS; Do AN; Ellenberger D; Pau CP; Paul S; Robbins K; Kalish M; Storck C; Schable CA; Wise H; Tetteh C; Jones JL; McFarland J; Yang C; Lal RB; Ward JW
    J Infect Dis; 2000 Feb; 181(2):463-9. PubMed ID: 10669327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.